On page 4 of this published article an error in [Figure 2(a)](#fig1){ref-type="fig"} has occurred. Accordingly, [Figure 2(a)](#fig1){ref-type="fig"} has been replaced with a corrected version of the figure as shown below.

![Phosphorylation of *α*-synuclein in *MsrA* ^−/−^ and wild-type (WT) brain extracts. (a) Tris-soluble and Urea-soluble brain extracts (40 *μ*g protein) of both mouse types were prepared as described in Section 2. These extracts were then incubated in the presence of additional brain-matched Tris-soluble extract (10 *μ*g protein, serving as a source for kinases), 25 mM Tris (pH 7.4), protease inhibitor cocktail (no-EDTA) (Roche), 1 mM CaCl~2~, 10 mM MgCl~2~, and 16.7 *μ*M \[*γ*-^32^P\]-ATP for 3 minutes at room temperature in a final volume of 50 *μ*L. Endogenous phosphorylation was stopped by addition of 10 mM EDTA, 10 mM EGTA, 1 mM cold ATP and was immediately placed on ice. Then, the samples were subjected to an immunoprecipitation by anti-*α*-synuclein antibodies or anti-MetO antibodies as described in Section 2. Thereafter, equal protein amounts of the immunoprecipitants were subjected to an SDS-gel electrophoresis (4--20%) followed by exposure of the gel to an X-ray film. Lanes 1, 3, 5, and 7 represent Tris-soluble fractions, and lanes 2, 4, 6, and 8 represent urea-soluble fractions. Syn: *α*-synuclein; ab: antibodies; kDA: molecular mass markers in kilo-Dalton. The detected band following the immunoprecipitation by anti-MetO antibodies was also denoted in the text as MetO-15.](JAA2012-415713.001){#fig1}
